The association between the IL-4, ADRβ2 and ADAM 33 gene polymorphisms and asthma in the Taiwanese population

Journal of the Chinese Medical Association

Volumn 75, Issue 12, 2012, Pages 635-643

  Chiang, Chi Huei ^a,b,c   Lin, Ming Wei ^b   Chung, Ming Yi ^b   Yang, Ueng Cheng ^b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

2 adrenergic receptor; ADAM33; Asthma; IL 4; Single nucleotide polymorphism (SNP)

Indexed keywords

ADAM PROTEIN; ALLERGEN; BETA 2 ADRENERGIC RECEPTOR; DISINTEGRIN AND METALLOPROTEASE 33; IMMUNOGLOBULIN E; INTERLEUKIN 4; METHACHOLINE; NUCLEIC ACID; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ASTHMA; ATOPY; CONTROLLED STUDY; EOSINOPHIL COUNT; FEMALE; FORCED EXPIRATORY VOLUME; GENE FREQUENCY; GENE LOCUS; GENE MUTATION; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; POPULATION; PROMOTER REGION; SENSITIVITY AND SPECIFICITY; SINGLE NUCLEOTIDE POLYMORPHISM; TAIWAN;

ADAM PROTEINS; ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; ASTHMA; FEMALE; HUMANS; INTERLEUKIN-4; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RECEPTORS, ADRENERGIC, BETA-2;

EID: 84870935779     PISSN: 17264901     EISSN: 17287731     Source Type: Journal    
DOI: 10.1016/j.jcma.2012.08.012     Document Type: Article

References (58)

1. Guideline of the Global Initiative for Asthma (GINA) for asthma management and prevention 2006, NHLBI/WHO Workshop Report. http://www.ginasthma.com.
2. Busse W.W., Banks-Schlegel S., Wenzel S.E. Pathophysiology of severe asthma. J Allergy Clin Immunol 2000, 106:1033-1042.
3. Richter A., Puddicombe S.M., Lordan J.L., Bucchieri F., Wilson S.J., Djukanovic R., et al. The contribution of interleukin (IL)-4 and IL-13 to the epithelial mesenchymal trophic unit in asthma. Am J Respir Cell Mol Biol 2001, 25:385-391.
4. Holloway J.W., Beghe B., Holgate S.T. The genetic basis of atopic asthma. Clin Exp Allergy 1999, 29:1023-1032.
5. Vercelli D. Discovering genes for asthma and allergy. Nat Rev Immunol 2008, 8:169-182.
6. A genome-wide search for asthma susceptibility loci in ethnically diverse populations. Nat Genet 1997, 15:389-392. The Collaborative Study on the Genetics of Asthma (CSGA).
7. Meyers D.A., Beaty T.H., Colyer C.R., Marsh D.G. Genetics of total serum IgE levels: a regressive model approach to segregation analysis. Genet Epidemiol 1991, 8:351-359.
8. Marsh D.G., Neely J.D., Breazeale D.R., Ghosh B., Freidhoff L.R., Ehrlich-Kautzky E., et al. Linkage analysis of IL4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations. Science 1994, 264:1152-1156.
9. Postma D.S., Bleecker E.R., Amelung P.J., Holroyd K.J., Xu J., Panhuysen C.I., et al. Genetic susceptibility to asthma-bronchial hyperresponsiveness coinherited with a major gene for atopy. N Engl J Med 1995, 333:894-900.
10. Van Eerdewegh P., Little R.D., Dupuis J., Del Mastro R.G., Falls K., Simon J., et al. Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness. Nature 2002, 418:426-430.
11. Steinke J.W., Borish L. Interleukin-4: its role in the pathogenesis of asthma, and targeting it for asthma treatment with interleukin-4 receptor antagonists. Respir Res 2001, 2:66-70.
12. Borish L., Mascali J.J., Klinnert M., Leppert M., Rosenwasser L.J. SSC polymorphisms in interleukin genes. Hum Mol Genet 1995, 4:974.
13. Coleman J.W., Holliday M.R., Kimber I., Zsebo K.M., Galli S.J. Regulation of mouse peritoneal mast cell secretory function by stem cell factor, IL-3 or IL-4. J Immunol 1993, 150:556-562.
14. Chiang C.H., Tang Y.C., Lin M.W., Chung M.Y. Association between the IL-4 promoter polymorphisms and asthma or severity of hyperresponsiveness in Taiwanese. Respirology 2007, 12:42-48.
15. Kawashima T., Noguchi E., Arinami T., Yamakawa-Kobayashi K., Nakagawa H., Otsuka F., et al. Linkage and association of an interleukin 4 gene polymorphism with atopic dermatitis in Japanese families. J Med Genet 1998, 35:502-504.
16. Noguchi E., Shibasaki M., Arinami T., Takeda K., Yokouchi Y., Kawashima T., et al. Association of asthma and the interleukin-4 promoter gene in Japanese. Clin Exp Allergy 1998, 28:449-453.
17. Walley A.J., Cookson W.O.C.M. Investigation of an interleukin-4 promoter polymorphism for associations with asthma and atopy. J Med Genet 1996, 33:689-692.
18. Reihsaus E., Innis M., MacIntyre N., Liggett S.B. Mutations in the gene encoding for the β2-adrenergic receptor in normal and asthmatic subjects. Am J Respir Cell Mol Biol 1993, 8:334-339.
19. 2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry 1994, 33:9414-9419.
20. 2 adrenoceptor Arg16Gly polymorphism, airway responsiveness, lung function and asthma in infants and children. Clin Exp Allergy 2004, 34:1043-1048.
21. 2-adrenergic receptor polymorphisms with severe asthma. Clin Exp Allergy 2000, 30:1097-1103.
22. 2-adrenergic receptor in nocturnal and nonnocturnal asthma: evidence that Gly16 correlates with the nocturnal phenotype. J Clin Invest 1995, 95:1635-1641.
23. 2 adrenergic receptor and the nocturnal asthma phenotype [in Chinese]. Sichuan Da Xue Xue BaoYi Xue Ban 2004, 35:32-34.
24. 2-adrenoceptor polymorphisms and asthma diagnosis among Mexican adults. J Allergy Clin Immunol 2003, 112:1095-1100.
25. 2-Adrenergic receptor Arg16/Arg16 genotype is associated with reduced lung function, but not with asthma, in the Hutterites. Am J Respir Crit Care Med 2000, 162:599-602.
26. 2-adrenoceptor polymorphism with lower airway reactivity in asthmatic subjects. Lancet 1995, 345:1213-1214.
27. 2-adrenoceptor (ADRB2) haplotypes: a population study. Am J Respir Crit Care Med 1998, 158:1968-1973.
28. 2-adrenoceptor polymorphism and bronchoprotective sensitivity with regular short- and long-acting β2-agonist therapy. Clin Sci 1999, 96:253-259.
29. 2 adrenoceptor with reported childhood asthma: population based study. BMJ 1998, 316:664.
30. 2-adrenergic receptor gene and bronchial asthma [in Chinese]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2002, 24:626-631.
31. 2-Adrenergic receptor polymorphisms and haplotypes are associated with airways hyperresponsiveness among nonsmoking men. Chest 2004, 126:66-74.
32. 2-adrenergic receptor polymorphisms with asthma phenotypes. J Allergy Clin Immunol 2005, 115:963-972.
33. 2-adrenoceptor polymorphisms and asthma: a HuGE review. Am J Epidemiol 2005, 162:201-211.
34. Primakoff P., Myles D.G. The ADAM gene family: surface proteins with adhesion and protease activity. Trends Genet 2000, 16:83-87.
35. Stone A.L., Kroeger M., Sang Q.X.A. Structure-function analysis of the ADAM family of disintegrin-like and metalloproteinase containing proteins. J Protein Chem 1999, 18:447-465.
36. Lee J.Y., Park S.W., Chang H.K., Kim H.Y., Rhim T.Y., Lee J.H., et al. A disintegrin and metalloproteinase 33 protein in patients with asthma relevance to airflow limitation. Am J Respir Crit Car Med 2006, 173:729-735.
37. Howard T.D., Postma D.S., Jongepier H., Moore W.C., Koppelman G.H., Zheng S.L., et al. Association of a disintegrin and metalloprotease (ADAM33) gene with asthma in ethnically diverse population. J Allergy Clin Immunol 2003, 112:717-722.
38. Werner M., Herbon N., Gohlke H., Altmuller J., Knappw M., Heinrich J., et al. Asthma is associated with single-nucleotide polymorphisms in ADAM33. Clin Exp Allergy 2004, 34:26-31.
39. Noguchi E., Ohtsuki Y., Tokunaga K., Yamaoka-Sageshima M., Ichikawa K., Aoki T., et al. ADAM33 polymorphisms are associated with asthma susceptibility in a Japanese population. Clin Exp Allergy 2006, 36:602-608.
40. Lee J.H., Park H.S., Park S.W., Jang A.S., Uh S.T., Rhim T., et al. ADAM33 polymorphism: association with bronchial hyper-responsiveness in Korean asthmatics. Clin Exp Allergy 2004, 34:860-865.
41. Lind D.L., Choudhry S., Ung N., Ziv E., Avila P.C., Salari K., et al. ADAM33 is not associated with asthma in Puerto Rican or Mexican populations. Am J Respir Crit Care Med 2003, 168:1312-1316.
42. Raby B.A., Silverman E.K., Kwiatkowski D.J., Lange C., Lazarus R., Weiss S.T. ADAM33 polymorphisms and phenotype associations in childhood asthma. J Allergy Clin Immunol 2004, 113:1071-1078.
43. Schedel M., Depner M., Schoen C., Weiland S.K., Vogelberg C., Niggemann B., et al. The role of polymorphisms in ADAM33, a disintegrin and metalloprotease 33, in childhood asthma and lung function in two German populations. Respir Res 2006, 19:91.
44. Wang P., Liu Q.J., Li J.S., Li H.C., Wei C.H., Guo C.H., et al. Lack of association between ADAM33 gene and asthma in a Chinese population. Int J Immunogenet 2006, 33:303-306.
45. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 1991, 144:1202-1218. American Thoracic Society.
46. Guideline for methacholine and exercise challenge test - 1999. This official statement of the American Thoracic Society was adopted by the ATS board of directors. Am J Respir Crit Care Med 1999, 2000:309-329. American Thoracic Society.
47. Kim S.H., Oh S.Y., Oh H.B., Kim Y.K., Cho S.H., Kim Y.Y., et al. Association of β2-adrenoreceptor polymorphisms with nocturnal cough among atopic subjects but not with atopy and nonspecific bronchial hyperresponsiveness. J Allergy Clin Immunol 2002, 109:630-635.
48. Basehore M.J., Howard T.D., Lange L.A., Moore W.C., Hawkins G.A., Marshik P.L., et al. A comprehensive evaluation of IL4 variants in ethnically diverse populations: association of total serum IgE level and asthma in white subjects. J. Allergy Clin Immunol 2004, 114:80-87.
49. Kabesch M., Tzotcheva I., Carr D., Hofler C., Weiland S.K., Fritzsch C., et al. A complete screening of the IL4 gene: novel polymorphisms and their association with asthma and IgE in childhood. J Allergy Clin Immunol 2003, 112:893-898.
50. Beghe B., Barton S., Rorke S., Peng Q., Sayers I., Gaunt T., et al. Polymorphisms in the interleukin-4 and interleukin-4 receptor alpha chain genes confer susceptibility to asthma and atopy in a Caucasian population. Clin Exp Allergy 2003, 33:1111-1117.
51. Hijazi Z., Haider M.Z. Interleukin-4 gene promoter polymorphism [C590T] and asthma in Kuwaiti Arabs. Int Arch Allergy Immunol 2000, 122:190-194.
52. Cui T., Wu J., Pan S., Xie J. Polymorphisms in the IL-4 and IL-4R [alpha] genes and allergic asthma. Clin Chem Lab Med 2003, 41:888-892.
53. Lia Y., Guob B., Lin Z., Hana J., Wua B., Xionga H. Association between C-589T polymorphisms of interleukin-4 gene promoter and asthma: a meta-analysis. Respir Med 2008, 102:984-992.
54. Rosenwasser L.J., Borish L. Promoter polymorphisms predisposing to the development of asthma and atopy. Clin Exp Allergy 1998, 28(Suppl 5):13-15.
55. Barr R.G., Cooper D.M., Speizer F.E., Drazen J.M., Camargo C.A. Beta (2)-adrenoceptor polymorphism and body mass index are associated with adult-onset asthma in sedentary but not active women. Chest 2001, 120:1474-1479.
56. Emala C.W., McQuitty C.K., Eleff S.M., Hopkins-Price P., Lawyer C., Hoh J., et al. Asthma, allergy, and airway hyperresponsiveness are not linked to the β2-adrenoceptor gene. Chest 2002, 121:722-731.
57. Holgate S.T., Yang Y., Haitchi H.M., Powell R.M., Holloway J.W., Yoshisue H., et al. The genetics of asthma: ADAM33 as an example of a susceptibility gene. Proc Am Thorac Soc 2006, 3:440-443.
58. Jongepier H., Boezen H.M., Dijkstra A., Howard T.D., Vonk J.M., Koppelman G.H., et al. Polymorphisms of the ADAM33 gene are associated with accelerated lung function decline in asthma. Clin Exp Allergy 2004, 34:757-760.